Is ABIVAX Société Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025?

ABIVAX Société Anonyme (NASDAQ:ABVX) is 1 of the hottest large-cap stocks of 2025. On December 16, Piper Sandler raised the firm’s terms people connected Abivax to $142 from $112, portion maintaining an Overweight standing connected the shares.

On the aforesaid day, Citizens raised the firm’s terms people connected ABIVAX Société Anonyme (NASDAQ:ABVX) to $131 from $114, portion keeping an Outperform standing connected the shares. The steadfast highlighted that Abivax’s Q3 2025 results and operational milestones, specifically noting that the Phase 3 ulcerative colitis information released successful August, reenforce the drug’s imaginable to redefine modular objective care.

A time before, connected December 15, Abivax reported currency and currency equivalents of €589.7 million, a important summation from the €144.2 cardinal held astatine the extremity of 2024. This liquidity surge was chiefly driven by a monolithic nationalist offering completed connected July 28, which generated ~$700.3 cardinal (€597.2 million) successful nett proceeds. Consequently, Abivax has extended its projected currency runway into the 4th fourth of 2027.

The company’s nett nonaccomplishment for the archetypal 9 months of 2025 widened to €254.1 million, compared to €136.9 cardinal during the aforesaid play successful 2024. This was mostly owed to an summation successful R&D expenses, which roseate by €25.4 cardinal to scope €133.4 million. These costs were driven by the progression of the ABTECT Phase 3 trials for obefazimod successful ulcerative colitis and Phase 2b trials for Crohn’s disease. Additionally, the institution saw a spike successful personnel-related expenses, specifically a €14.8 cardinal summation successful leader contributions, triggered by a important emergence successful the company’s stock terms during Q3 2025.

ABIVAX Société Anonyme (NASDAQ:ABVX) is simply a clinical-stage biotechnology institution that develops therapeutics that harness the body’s earthy regulatory mechanisms to stabilize the immune effect successful patients with chronic inflammatory diseases.

While we admit the imaginable of ABVX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.